V Michael Ferdinandi Net Worth

The estimated Net Worth of V Michael Ferdinandi is at least $3.01 Million dollars as of 19 August 2009. V Ferdinandi owns over 5,657 units of CVS Health Corp stock worth over $898,938 and over the last 22 years V sold CVS stock worth over $2,108,641.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

V Ferdinandi CVS stock SEC Form 4 insiders trading

V has made over 5 trades of the CVS Health Corp stock since 2005, according to the Form 4 filled with the SEC. Most recently V sold 5,657 units of CVS stock worth $195,223 on 19 August 2009.

The largest trade V's ever made was exercising 139,080 units of CVS Health Corp stock on 23 May 2008 worth over $3,374,081. On average, V trades about 21,092 units every 82 days since 2003. As of 19 August 2009 V still owns at least 16,021 units of CVS Health Corp stock.

You can see the complete history of V Ferdinandi stock trades at the bottom of the page.

What's V Ferdinandi's mailing address?

V's mailing address filed with the SEC is , , , , .

Insiders trading at CVS Health Corp

Over the last 22 years, insiders at CVS Health Corp have traded over $183,836,314 worth of CVS Health Corp stock and bought 424,315 units worth $17,621,990 . The most active insiders traders include Michael F Mahoney, Thomas M Ryan, and Larry J Merlo. On average, CVS Health Corp executives and independent directors trade stock every 25 days with the average trade being worth of $4,897,842. The most recent stock trade was executed by Edward J Ludwig on 2 May 2024, trading 1,000 units of CVS stock currently worth $53,880.

What does CVS Health Corp do?

CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands.

Complete history of V Ferdinandi stock trades at CVS Health Corp

CVS Health Corp executives and stock owners

CVS Health Corp executives and other stock owners filed with the SEC include:

• Larry Merlo,
  President, Chief Executive Officer, Director
• Thomas Moriarty,
  Executive Vice President, General Counsel, Chief Policy and External Affairs Officer
• Jonathan Roberts,
  Chief Operating Officer, Executive Vice President
• Eva Boratto,
  Chief Financial Officer, Executive Vice President
• Troyen Brennan,
  Executive Vice President, Chief Medical Officer
• Eva C. Boratto,
  Exec. VP & CFO
• Jonathan C. Roberts,
  Exec. VP & COO
• Karen Sue Lynch,
  Pres, CEO & Director
• Dr. Alan M. Lotvin,
  Exec. VP & Pres of CVS Caremark
• David Dorman,
  Independent Chairman of the Board
• Edward Ludwig,
  Independent Director
• C. David Brown,
  Independent Director
• Nancy-Ann DeParle,
  Independent Director
• Anne Finucane,
  Independent Director
• Tony White,
  Independent Director
• Jean-Pierre Millon,
  Independent Director
• Alecia DeCoudreaux,
  Independent Director
• William Weldon,
  Independent Director
• Mary Schapiro,
  Independent Director
• Roger Farah,
  Independent Director
• Fernando Aguirre,
  Independent Director
• James Clark,
  Senior Vice President - Controller, Chief Accounting Officer
• Karen Lynch,
  Executive Vice President
• Alan Lotvin,
  Executive Vice President, President - CVS Caremark
• Joshua Flum,
  Executive Vice President - Enterprise Strategy and Digital
• Lisa Bisaccia,
  Chief Human Resource Officer, Executive Vice President
• Norman de Greve,
  Chief Marketing Officer & Director
• Thomas Michael Moriarty,
  Exec. VP, Chief Policy & External Affairs Officer and Gen. Counsel
• Susan V. Lisa,
  Sr. VP of Investor Relations
• James David Clark,
  Sr. VP, Controller & Chief Accounting Officer
• Shawn Michael Guertin,
  Exec. VP & CFO
• Katie Durant,
  Sr. Director of Investor Relations
• Eileen Howard Boone,
  Sr. VP & Chief Sustainability Officer
• Laurie P. Havanec,
  Exec. VP & Chief People Officer
• David A. Falkowski,
  Exec. VP & Chief Compliance Officer
• Valerie C. Haertel,
  Sr. VP of Investor Relations
• Neela Montgomery,
  EVP and Pres., Pharmacy/Retail
• J. David Joyner,
  EVP&President-PharmacyServices
• Andrew Sussman,
  SVP & President, MinuteClinic
• Richard M Bracken,
  Director
• Robert O. Kraft,
  EVP and President - Omnicare
• Richard J Swift,
  Director
• David M Denton,
  Controller
• Stephen J Gold,
  SVP & CIO
• Thomas F. Cowhey,
  EVP and CFO
• Jonathan E. Mayhew,
  EVP - Transformation
• Kevin Hourican,
  EVP & President, CVS Pharmacy
• Mark T Bertolini,
  Director
• Derica W Rice,
  EVP & President, CVS Caremark
• Helena Foulkes,
  Senior Vice President
• Kristen Gibney Williams,
  Director
• C A Piccolo,
  Director
• Mark Cosby,
  EVP & President-CVS/pharmacy
• Laird Daniels,
  SVP, Cont & Chief Acct Officer
• Howard A Mclure,
  President, Caremark Pharm Serv
• Chris W Bodine,
  Executive Vice President
• Paula A Price,
  Controller
• Edwin M Banks,
  Director
• David B Rickard,
  Chief Financial Officer
• V Michael Ferdinandi,
  Senior Vice President
• Roger L Headrick,
  Director
• William R Spalding,
  EVP Caremark Pharmacy Services
• Edwin M Crawford,
  Chairman
• Stuart M Mcguigan,
  SVP and CIO
• Thomas M Ryan,
  Chairman & CEO
• Terrence Murray,
  Director
• Marian L Heard,
  Director
• Sara Finley,
  SVP, Gen Counsel
• Douglas A Sgarro,
  Vice President
• Sheli Z Rosenberg,
  Director
• William H Joyce,
  Director
• W Don Cornwell,
  Director
• Gregory S Weishar,
  Vice President
• Alfred J Verrecchia,
  Director
• Larry D Solberg,
  Senior Vice President
• Stanley P Goldstein,
  Director
• Thomas P Gerrity,
  Director
• Terry R Lautenbach,
  Director
• Per Gh Lofberg,
  President, Caremark Pharm Serv
• Brian A Kane,
  EVP/President, Aetna
• Laurie P. Havanec,
  EVP and Chief People Officer
• J Scott Kirby,
  Director
• Daniel P Finke,
  EVP/Pres, Health Care Benefits
• Prem S Shah,
  EVP and Pres-Pharm, Consumer W
• Shawn M Guertin,
  EVP & Chief Financial Officer
• Michelle A Peluso,
  EVP and Co-President of Retail
• Sreekanth K Chaguturu,
  EVP and Chief Medical Officer
• Jeffrey R. Balser,
  Director
• Tilak Mandadi,
  EVP, Chief Technology Officer
• Samrat S. Khichi,
  EVP, CPO and General Counsel
• Michael F Mahoney,
  Director